Kathleen Squires

9.4k total citations · 3 hit papers
80 papers, 6.9k citations indexed

About

Kathleen Squires is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Kathleen Squires has authored 80 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Infectious Diseases, 44 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Kathleen Squires's work include HIV/AIDS drug development and treatment (52 papers), HIV/AIDS Research and Interventions (48 papers) and HIV Research and Treatment (44 papers). Kathleen Squires is often cited by papers focused on HIV/AIDS drug development and treatment (52 papers), HIV/AIDS Research and Interventions (48 papers) and HIV Research and Treatment (44 papers). Kathleen Squires collaborates with scholars based in United States, United Kingdom and France. Kathleen Squires's co-authors include Judith S. Currier, Margaret A. Fischl, Scott M. Hammer, Lisa M. Demeter, Judith Feinberg, Bach‐Yen Nguyen, Michael D. Hughes, Joseph J. Eron, Jon C. Cook and John Phair and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Kathleen Squires

77 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 2.1k citations Scott M. Hammer, Kathleen Squires et al. New England Journal of Medicine profile →
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1995 810 citations Kathleen Squires et al. profile →
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

2007 634 citations Jialing Huang, Fengxiang Wang et al. Nature Medicine profile →

Peers

Countries citing papers authored by Kathleen Squires

Since Specialization

Citations

This map shows the geographic impact of Kathleen Squires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Squires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Squires more than expected).

Fields of papers citing papers by Kathleen Squires

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Squires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Squires. The network helps show where Kathleen Squires may publish in the future.

Co-authorship network of co-authors of Kathleen Squires

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Squires. A scholar is included among the top collaborators of Kathleen Squires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Squires. Kathleen Squires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial 2025 ·Clinical Infectious Diseases ·Jürgen K. Rockstroh, Roger Paredes, Pedro Cahn, Jean‐Michel Molina, Simiso Sokhela, Federico Hinestrosa, Sheetal Kassim, Douglas Cunningham, Jade Ghosn, Johannes R. Bogner, Hiroyuki Gatanaga, Ernest Asante‐Appiah, Ying Zhang, (unknown), Stephanie O. Klopfer, Karen Eves, Kathleen Squires, (unknown), Michelle C. Fox, (unknown)	0
2	P075 Efficacy and safety of switching to EVG/COBI/FTC/TAF in virologically suppressed women 2017 ·Sexually Transmitted Infections ·Sally Hodder, Kathleen Squires, Cissy Kityo, Anchalee Avihingsanon, (unknown), Shuping Jiang, Rima Kulkarni, Andrew Cheng, (unknown), Huyen Cao	1
3	Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study 2016 ·The Lancet HIV ·Kathleen Squires, Cissy Kityo, Sally Hodder, Margaret Johnson, Evgeny Voronin, Debbie Hagins, Anchalee Avihingsanon, Ellen Koenig, Shuping Jiang, Kirsten White, Andrew Cheng, Javier Szwarcberg, Huyen Cao	62
4	Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 144 Weeks with Abacavir/Lamivudine/Atazanavir with or without Ritonavir in ARIES 2012 ·AIDS Research and Human Retroviruses ·Benjamin Young, Kathleen Squires, Lisa Ross, Lizette Santiago, Louis Sloan, Henry Zhao, (unknown), Gary E. Pakes, David A. Margolis, Mark S. Shaefer	17
5	Health Needs of HIV-Infected Women in the United States: Insights from The Women Living Positive Survey 2011 ·AIDS Patient Care and STDs ·Kathleen Squires, Sally Hodder, Judith Feinberg, (unknown), (unknown), Stephen P. Storfer, Judith A. Aberg	56
6	Recruitment and Retention of Diverse Populations in Antiretroviral Clinical Trials: Practical Applications from the Gender, Race And Clinical Experience Study 2011 ·Journal of Women s Health ·(unknown), (unknown), Judith S. Currier, Kathleen Squires, Debbie Hagins, (unknown), Robert J. Ryan, (unknown)	39
7	Prevalence of obstructive lung disease in HIV population: A cross sectional study 2011 ·Respiratory Medicine ·Amyn Hirani, Rodrigo Cavallazzi, Tajender S. Vasu, Monvasi Pachinburavan, Walter K. Kraft, Benjamin E. Leiby, William R. Short, Joseph DeSimone, Kathleen Squires, (unknown), Gregory C. Kane	46
8	A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen 2010 ·HIV Clinical Trials ·Scott M. Hammer, Heather J. Ribaudo, Roland Bassett, John W. Mellors, Lisa M. Demeter, Robert W. Coombs, Judith S. Currier, Gene D. Morse, John G. Gerber, Ana I. Martínez, William Spreen, Margaret A. Fischl, Kathleen Squires, (unknown)	16
9	A Novel Codon Insert in Protease of Clade B HIV Type 1 2009 ·AIDS Research and Human Retroviruses ·(unknown), Art F. Y. Poon, Joseph J. Eron, Kathleen Squires, Caroline Ignacio, Douglas D. Richman, Davey M. Smith	2
10	Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy 2008 ·Journal of the American College of Cardiology ·Francesca J. Torriani, Lauren Komarow, Robert A. Parker, Bruno Cotter, Judith S. Currier, Michael P. Dubé, Carl J. Fichtenbaum, Mariana Gerschenson, Carol K.C. Mitchell, Robert L. Murphy, Kathleen Squires, James H. Stein	241
11	The Costs of HIV Antiretroviral Therapy Adherence Programs and Impact on Health Care Utilization 2008 ·AIDS Patient Care and STDs ·Stephanie L. Sansom, (unknown), Wendy Garland, Kathleen Squires, Mallory D. Witt, (unknown), Robert A. Larsen, (unknown), Sherri Pals, Shannon Hader, Paul J. Weidle, Amy Rock Wohl	16
12	Factors Influencing the Acceptance of Changes in Antiretroviral Therapy among HIV-1–Infected Patients 2007 ·AIDS Patient Care and STDs ·Rafael Campo, S Narayanan, Patrick G. Clay, Jack DeHovitz, Debra Johnson, Wilbert Jordan, Kathleen Squires, Shiva G. Sajjan, Leona E. Markson	6
13	Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes breakdown → 2007 ·Nature Medicine ·Jialing Huang, Fengxiang Wang, Elias G. Argyris, Keyang Chen, Zhihui Liang, (unknown), Wenlin Huang, Kathleen Squires, (unknown), Hui Zhang	634
14	Severe Cholestatic Liver Injury Days After Initiating Antiretroviral Therapy in a Patient with AIDS: Drug Toxicity or Immune Reconstitution Inflammatory Syndrome? 2005 ·Digestive Diseases and Sciences ·Sumita Verma, (unknown), (unknown), Shireen Pais, Gary C. Kanel, Kathleen Squires	1
15	Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection 2004 ·New England Journal of Medicine ·Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma, Stephanie Lustgarten, Kathleen Squires, William A. Meyer, Edward P. Acosta, Bruce R. Schackman, Christopher D. Pilcher, Robert L. Murphy, William E. Maher, Mallory D. Witt, Richard C. Reichman, Sally Snyder, Karin L. Klingman, Daniel R. Kuritzkes	396
16	Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248) 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mary Vogler, Hedy Teppler, Rebecca Gelman, Fred Valentine, Michael M. Lederman, Roger J. Pomerantz, Richard B. Pollard, (unknown), Charles J. Gonzalez, Kathleen Squires, Ian Frank, Donna Mildvan, (unknown), Barbara Schock	15
17	Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kathleen Squires, Adriano Lazzarin, (unknown), William G. Powderly, Vadim Pokrovskiy, (unknown), Joseph G. Jemsek, Antonio Rivero, Willy Rozenbaum, Shannon Schrader, Michael Sension, Asda Vibhagool, Alexandra Thiry, Michael Giordano	238
18	Incidence and Risk Factors for Sexually Transmitted Infections among Women in an Alabama HIV Clinic 2004 ·AIDS Research and Human Retroviruses ·(unknown), Laura H. Bachmann, Renée A. Desmond, Kathleen Squires, Sten H. Vermund, Edward W. Hook, Jane R. Schwebke, Craig Hoesley	5
19	Once‐Daily Quadruple‐Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment‐Naive Human Immunodeficiency Virus Type 1–Infected Patients 2002 ·The Journal of Infectious Diseases ·Gail Skowron, Daniel R. Kuritzkes, Melanie Thompson, Kathleen Squires, Shirley Goodwin, Betsy A. Dusak, Jerry M. Tolson, M. L. Stevens, Geoffrey J. Yuen, James F. Rooney	10
20	Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients 1988 ·The American Journal of Medicine ·(unknown), Barry J. Hartman, P. K. Sharkey, (unknown), Kathleen Squires, Henry W. Murray, John R. Graybill	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact